Have you ever wondered why some treatments for acne vulgaris work for some but not others? This common skin condition, affecting millions of adolescents and young adults, is far more complex than it appears. Its development involves a mix of genetic, hormonal, microbial, and inflammatory factors, making it a challenge to treat effectively¹.

Recent advancements in dermatology have shed light on the underlying causes of this condition. For instance, elevated levels of IL-17 and Th17 cells in acne lesions highlight the role of inflammation in its progression¹. Additionally, new treatments like sarecycline, the first oral antibiotic approved in 40 years, offer hope for those struggling with moderate-to-severe cases².

In this article, we explore the intricate mechanisms behind acne and the latest therapeutic innovations. From traditional methods to cutting-edge treatments, we aim to provide a comprehensive guide for clinicians and researchers alike. Understanding these advancements is crucial for developing personalized approaches to care.

Key Takeaways

• Acne vulgaris involves multiple factors, including genetics, hormones, and inflammation.
• New treatments like sarecycline offer targeted solutions for severe cases.
• Inflammation plays a key role in acne development, with elevated IL-17 levels observed.
• Personalized approaches are essential due to the condition’s complexity.
• Emerging therapies focus on reducing bacterial resistance and improving outcomes.

Introduction

Skin health is deeply influenced by a combination of biological and environmental factors. One of the most common conditions affecting millions globally is acne vulgaris. This condition, prevalent among adolescents and adults, involves a complex interplay of sebaceous gland activity, follicular changes, and microbial colonization³.

The development of acne lesions is primarily driven by sebaceous gland hyperactivity and follicular hyperkeratinization. These changes create an environment where bacteria, particularly Cutibacterium acnes, thrive, leading to inflammation and visible skin issues³. Understanding these mechanisms is crucial for developing effective treatments.

Overview of Acne Pathophysiology

Acne vulgaris is not just a surface-level issue. It involves multiple biological processes, including hormonal influences and immune responses. Elevated levels of IL-17 and Th17 cells in acne lesions highlight the role of inflammation in its progression³. This complexity makes it a challenging condition to manage effectively.

Purpose and Scope of Our Review

Our review aims to provide a comprehensive understanding of acne, from its basic pathophysiology to the latest treatment strategies. We integrate recent clinical studies with mechanistic insights to offer a holistic view. This approach helps clinicians and researchers alike in developing personalized care plans.

Background on Acne Vulgaris

Understanding the root causes of skin issues can lead to more effective treatments. Acne vulgaris, a common condition, affects millions of people worldwide. It represents 99% of all acne cases and is characterized by both inflammatory and non-inflammatory lesions⁴.

This condition primarily impacts teens and young adults, with a higher prevalence in those with a family history of the issue⁴. The skin’s health is influenced by a mix of internal and external factors, making it essential to understand its complexity.

Common Forms and Characteristic Lesions

Acne vulgaris presents in various forms, including open and closed comedones, papules, pustules, nodules, and cysts. These lesions are the result of multiple factors affecting the skin, such as hormonal changes and microbial activity⁵.

Open comedones, often called blackheads, occur when pores are clogged with oil and dead skin cells. Closed comedones, or whiteheads, form when the pore is completely blocked. Inflammatory lesions like papules and pustules arise when bacteria invade the clogged pores, leading to redness and swelling⁵.

Nodules and cysts are more severe forms of acne. They develop deeper within the skin and can cause significant discomfort. Understanding these lesions is crucial for accurate diagnosis and effective treatment planning⁴.

Factors such as genetics, diet, and environmental influences play a role in lesion formation. For instance, high-glycemic-index foods and dairy products have been linked to increased acne severity⁴. Recognizing these factors helps in tailoring therapies to individual needs.

Distinguishing between lesion types is vital for treatment. For example, non-inflammatory comedones may respond well to topical treatments, while severe inflammatory lesions often require systemic therapies⁵. A thorough understanding of these skin factors ensures better outcomes for patients.

Multifactorial Etiology and Pathogenesis of Acne

The development of skin conditions is often shaped by a mix of genetic and environmental factors. This multifactorial nature makes it essential to understand the various agents contributing to their pathogenesis. By examining these influences, we can design more effective management strategies tailored to individual needs.

Genetic Influences and Hereditary Factors

Genetic predisposition plays a significant role in the severity and persistence of skin issues. Studies show that individuals with a family history of these conditions are more likely to experience them⁴. This hereditary link underscores the importance of genetic factors as a key agent in their development.

For example, familial risk is notably higher, with first-degree relatives of affected individuals having a 63% likelihood of developing similar issues⁶. This highlights the need for personalized approaches in management.

Environmental and Lifestyle Contributors

External factors, such as diet and stress, also significantly impact skin health. High-glycemic-index foods and dairy products have been linked to increased severity of skin conditions due to their influence on insulin-like growth factor 1 (IGF-1) signaling⁴.

Additionally, emotional stress can alter the gut microbiome, leading to systemic inflammation that exacerbates skin issues⁴. Understanding these environmental agents is crucial for effective management.

By addressing both genetic and environmental factors, we can better understand the pathogenesis acne and develop comprehensive management strategies. This holistic approach ensures improved outcomes for individuals dealing with these conditions.

Hormonal Impacts on Acne Development

Hormonal changes play a pivotal role in the development of skin issues. These shifts influence sebum production, inflammation, and overall skin health. Understanding these mechanisms is essential for effective treatment acne vulgaris.

Role of Androgens and IGF-1

Androgens, such as testosterone, significantly impact sebaceous gland activity. Elevated levels can lead to increased oil production, clogged pores, and inflammation⁷. Insulin-like growth factor 1 (IGF-1) also plays a critical role by stimulating sebum production and exacerbating skin conditions⁸.

During adolescence, hormonal fluctuations often trigger skin issues. However, these changes can persist into adulthood, particularly in women with conditions like polycystic ovary syndrome (PCOS)⁷. Addressing these hormonal imbalances is key to managing skin health effectively.

Influence of Neuropeptides and Systemic Hormones

Neuropeptides, such as corticotropin-releasing hormone (CRH) and substance P, contribute to inflammatory processes in the skin. These molecules are often elevated in individuals with persistent skin issues⁹.

Systemic hormones, including those related to stress and metabolism, also affect skin health. For example, elevated cortisol levels can worsen inflammation and delay healing⁸. Tailoring treatment acne vulgaris to address these hormonal factors can improve outcomes for adult patients.

By understanding the complex interplay of hormones, we can develop more personalized and effective strategies for managing skin conditions. This approach ensures better results for individuals seeking long-term solutions.

Role of Sebaceous Glands in Acne

Sebaceous glands are central to understanding why skin issues persist. These glands, found throughout the skin, produce sebum, an oily substance that moisturizes and protects the skin. However, when sebum production becomes dysregulated, it creates an environment conducive to bacterial growth and inflammation¹⁰.

The functional anatomy of sebaceous glands reveals their critical role in skin health. They are most concentrated in areas like the face and scalp, where skin issues often arise¹¹. Overproduction of sebum can clog pores, leading to the formation of lesions. This process is a key factor in the development of persistent skin problems.

Dysregulated sebaceous activity contributes significantly to skin inflammation. When sebum mixes with dead skin cells, it creates a plug that traps bacteria, particularly Cutibacterium acnes. This bacterial colonization triggers an immune response, resulting in redness and swelling¹⁰.

Effective treatment acne strategies often target sebum production and bacterial load. For example, benzoyl peroxide is a widely used treatment that reduces sebum and kills bacteria directly¹². By addressing these factors, we can improve outcomes for individuals dealing with persistent skin issues.

Understanding sebaceous gland dysfunction is essential for developing both topical and systemic therapies. Insights into glandular activity help us tailor treatments to individual needs, ensuring better results. This approach is particularly important for those with severe or recurrent skin problems.

Microbiome Interactions in Acne Pathogenesis

The skin microbiome plays a critical role in maintaining health and preventing disease. Its balance is essential for preventing inflammation and the formation of lesions. When this balance is disrupted, conditions like acne can develop¹³.

Contributions of Cutibacterium acnes

Cutibacterium acnes is a central player in the development of skin inflammation. This bacterium thrives in sebum-rich environments, such as the face and scalp, and can trigger immune responses that lead to redness and swelling¹⁴. Studies from PubMed show that certain strains of C. acnes are more likely to cause severe acne lesions¹³.

For example, strains from clades IA-2, IB-1, and IC are closely associated with acne, while type II strains are often found in healthy skin¹⁴. This distinction highlights the importance of understanding bacterial diversity in developing targeted treatments.

The Gut-Skin Axis and Dysbiosis

Emerging research emphasizes the connection between gut health and skin conditions. Dysbiosis, or an imbalance in gut bacteria, can exacerbate inflammation and worsen acne¹³. A Western diet, high in sugar and fat, has been linked to changes in gut microbiota that negatively impact skin health¹⁴.

Restoring microbial balance through probiotics and dietary changes is a promising approach. Evidence from dermatol studies supports the idea that a healthy gut can lead to clearer skin¹³.

Understanding these microbial interactions is key to developing novel treatment approaches. By targeting both the skin and gut microbiome, we can create more effective strategies for managing acne lesions¹⁴.

Immunological Aspects and Inflammatory Pathways

The immune system plays a crucial role in the development and progression of skin conditions. Both innate and adaptive immune responses are activated in acne, contributing to inflammation and lesion formation¹⁵. Understanding these pathways is essential for developing targeted therapies.

Activation of Innate Immune Responses

The innate immune system is the first line of defense against microbial triggers. In acne, it recognizes Cutibacterium acnes as a foreign invader, initiating an inflammatory response¹⁶. Neutrophils, macrophages, and other immune cells are recruited to the site, leading to redness and swelling¹⁷.

Studies show that neutrophils are present in 33% of acne lesions within 72 hours of development¹⁶. This rapid response highlights the importance of innate immunity in the early stages of inflammation.

Adaptive Immunity and Cytokine Dynamics

Adaptive immunity further amplifies the inflammatory cascade. T-cells, particularly Th17 cells, play a significant role in acne pathogenesis¹⁵. These cells release cytokines like IL-1β, IL-6, and TNFα, which exacerbate inflammation and contribute to lesion formation¹⁶.

Research indicates that the Th17/Treg balance is disrupted in acne, leading to chronic inflammation¹⁷. Modulating this balance is a key focus of current therapy research.

Advancing our understanding of these immunological pathways is critical for developing effective treatments. By targeting both innate and adaptive immune responses, we can reduce chronic inflammation and improve outcomes for patients¹⁵.

Acne Pathophysiological Mechanisms to Emerging Therapies

The treatment landscape for skin conditions is rapidly evolving, with new approaches offering hope for better outcomes. Our review highlights the transition from understanding basic mechanisms to developing innovative therapies. This shift is driven by advancements in both topical and systemic interventions.

Innovative Topical and Systemic Interventions

Next-generation retinoid formulations are leading the way in topical treatments. These agents target the sebaceous gland, reducing oil production and inflammation¹⁸. Clinical studies show that these retinoids normalize hyperkeratinization, a key factor in lesion formation¹⁹.

Systemic interventions are also making strides. Hormonal regulators and novel antibiotics are being evaluated for their efficacy in managing severe cases³. For example, clascoterone cream has shown promising results in reducing lesions by over 50% in clinical trials³.

Future Directions in Therapeutic Research

Emerging therapies like bacteriophages and probiotics are gaining attention. These treatments aim to restore microbial balance, addressing the root causes of inflammation³. Peptide-based therapies are also being explored for their ability to modulate immune responses¹⁸.

Our review synthesizes both established and cutting-edge data to define future therapeutic directions. Translating these findings into real-world protocols remains a focus of ongoing research¹⁹.

Topical Treatment Modalities and Their Efficacy

Effective skin care often starts with understanding the tools at our disposal. Topical treatments are fundamental in managing skin health, offering targeted solutions for various concerns. These treatments work directly on the skin, addressing issues like clogged pores, bacterial growth, and inflammation²⁰.

Retinoids and Benzoyl Peroxide in Focus

Retinoids are among the most well-studied topical agents. They normalize cell turnover, reducing the formation of clogged pores and inflammation²¹. Clinical studies show that retinoids are effective as monotherapy or in combination with other treatments²⁰.

Benzoyl peroxide is another cornerstone of topical care. It targets bacterial proliferation and sebum production, making it a versatile option for managing skin health²¹. Its bactericidal activity ensures quick results without inducing resistance²⁰.

Antibiotics and Alternative Topical Agents

Topical antibiotics like erythromycin and clindamycin are commonly used, but resistance has become a concern²⁰. To address this, alternative agents like azelaic acid and dapsone are gaining traction. These options offer antibacterial and anti-inflammatory benefits with fewer resistance risks²¹.

Combining these treatments can enhance efficacy. For example, retinoids and benzoyl peroxide work synergistically to reduce lesions and inflammation²⁰. This approach ensures comprehensive care for individuals seeking clearer skin.

Systemic and Hormonal Therapies for Severe Acne

When topical treatments fall short, systemic and hormonal therapies step in to address severe cases. These approaches target deeper cellular mechanisms, offering solutions for patients who don’t respond to surface-level treatments¹⁸.

Oral antibiotics are often the first line of defense in systemic therapy. They reduce bacterial load and inflammation, addressing the root causes of severe lesions²². Common options include tetracyclines and macrolides, which have shown significant efficacy in clinical trials²³.

Hormonal agents, such as anti-androgens, play a crucial role in managing acne in adult patients. By modulating androgen levels, these treatments regulate sebum production and reduce lesion formation¹⁸. This approach is particularly effective for women with hormonal imbalances like polycystic ovary syndrome (PCOS)²².

Understanding the cellular mechanisms behind severe acne is key to choosing the right therapy. For example, elevated levels of inflammatory cytokines like IL-1β and TNFα contribute to persistent lesions¹⁸. Systemic treatments target these pathways, offering long-term relief.

Current studies compare the efficacy and safety of systemic agents against topical treatments. While systemic therapies are more potent, they require careful monitoring to avoid side effects²³. For more insights, explore the latest therapeutic advancements in acne management.

Our review synthesizes data from clinical research, emphasizing practical considerations for therapy in severe cases. By integrating systemic and hormonal approaches, we aim to improve outcomes for patients with challenging conditions²².

Procedural and Laser Treatments Overview

Procedural treatments are revolutionizing how we manage persistent skin concerns. These advanced methods target deeper layers of the skin, offering solutions for those who don’t respond to traditional therapies. From lasers to chemical peels, these treatments are reshaping the landscape of skin care²⁴.

Insights into Photodynamic Therapy and Laser Applications

Photodynamic therapy (PDT) uses light-activated drugs to target and destroy problematic cells. Studies show that PDT with methyl aminolevulinate acid (MAL) is effective for moderate to severe cases²⁴. This therapy reduces inflammation and bacterial counts, making it a powerful adjunct to traditional treatments.

Laser applications, such as pulsed dye lasers (PDLs), emit specific wavelengths to treat skin issues. PDLs have been validated for decreasing inflammatory lesions since 2003²⁴. These lasers interact with skin receptors, promoting healing and reducing scarring.

Chemical Peels and Intralesional Injections

Chemical peels exfoliate the skin, removing dead cells and promoting renewal. They are particularly effective for mild to moderate cases, offering quick results with minimal downtime²⁵. Peels containing salicylic acid or glycolic acid are commonly used.

Intralesional injections deliver drugs directly into problematic areas. This method reduces inflammation and accelerates healing. For example, corticosteroids are often used to treat severe nodules and cysts⁴.

These procedural treatments are supported by clinical studies, demonstrating their efficacy as adjuncts to traditional regimens²⁴. Individualized approaches, tailored to each patient’s unique skin characteristics, ensure the best outcomes.

Emerging Therapies: Novel Approaches

Innovative treatments are reshaping how we approach persistent skin concerns. Moving beyond traditional methods, these new strategies focus on restoring balance and targeting specific issues. They offer hope for those who haven’t found relief with conventional options.

Bacteriophages: Precision Targeting

Bacteriophage therapy is gaining attention for its ability to specifically target propionibacterium, a key player in skin issues. These viruses attack harmful bacteria without disrupting the skin’s natural microbiome²⁶. Early studies show promising results in reducing inflammation and irritation²⁷.

Probiotics: Restoring Balance

Probiotics are emerging as a powerful tool for skin health. By restoring microbial balance, they help reduce irritation and improve overall skin condition²⁶. Clinical trials have demonstrated their effectiveness in managing persistent concerns²⁸.

Peptides: Innovative Solutions

Peptides are small proteins that play a big role in skin repair. They modulate immune responses and promote healing, making them a valuable addition to modern med protocols²⁷. Their ability to reduce inflammation and irritation has been well-documented in preclinical studies²⁶.

These emerging therapies represent a shift toward personalized care. By targeting the root causes of skin issues, they offer more effective and lasting solutions. Future research will continue to refine these treatments, improving outcomes for patients worldwide.

Personalized Approaches in Acne Management

Personalized care is transforming how we address skin concerns. With variations in hormone levels, genetics, and lifestyle, a one-size-fits-all approach often falls short. Tailored treatment plans are essential to meet individual needs and improve outcomes²⁹.

For women, hormonal imbalances like hyperandrogenism significantly influence skin health. Polycystic ovary syndrome (PCOS) affects 51% of patients with severe cases, highlighting the need for gender-specific strategies²⁹. Understanding these factors ensures more effective action.

Tailoring Treatment to Individual Profiles

Genetic, immunological, and microbial profiles play a key role in treatment success. For example, certain strains of Cutibacterium acnes are linked to severe inflammation, while others are found in healthy skin³⁰. Personalized therapies target these differences, offering better results.

Resistance to standard treatments is a growing concern. Studies show that 48% of patients in Asia struggle with adherence due to side effects²⁹. Customized plans can overcome this by addressing specific patient needs and minimizing adverse reactions.

Case examples demonstrate the positive impact of individualized care. For instance, a patient with persistent lesions saw significant improvement after switching to a tailored regimen³⁰. These success stories underscore the importance of personalized approaches.

Effective action requires an integrated analysis of patient-specific factors. Combining genetic insights, lifestyle adjustments, and evidence-based treatments ensures comprehensive care. For more insights, explore personalized acne management strategies.

Evaluating Current Research and PubMed Insights

Recent advancements in dermatological research have reshaped our understanding of effective treatment strategies. By integrating comprehensive PubMed data, we can better evaluate the efficacy of various therapies. This section highlights key findings from clinical studies and meta-analyses, offering a data-driven perspective on modern management approaches.

Recent Clinical Studies and Meta-Analyses

Clinical studies have shown that benzoyl peroxide remains a cornerstone in treatment regimens. Available in concentrations ranging from 2.5% to 10%, it effectively reduces bacterial load and inflammation³¹. Meta-analyses confirm its efficacy, especially when combined with other agents like topical retinoids³².

Chemical peels have also gained attention for their ability to exfoliate and rejuvenate the skin. Studies indicate that peels containing salicylic acid significantly reduce lesion counts and improve skin texture³³. These findings support their use as adjuncts to traditional therapies.

Research targeting the sebaceous gland has revealed new insights into its role in skin health. Dysregulated gland activity is a key factor in lesion formation, and therapies that normalize its function show promising results³¹. For example, retinoids like adapalene have been validated for their ability to regulate gland activity and reduce inflammation³².

Our review synthesizes these findings to provide an up-to-date perspective on treatment strategies. By leveraging evidence-based data, we aim to guide clinical decisions and improve patient outcomes. For more insights, explore the latest therapeutic advancements in acne management.

Integrating Innovations in Clinical Practice

Bridging the gap between research and clinical practice is essential for modern dermatology. We explore how cutting-edge findings are translated into everyday protocols, ensuring patients benefit from the latest advancements.

Translating Research Findings to Daily Treatment

Case studies demonstrate the successful implementation of novel treatment mechanisms. For example, therapies targeting sebum production have shown significant improvements in reducing inflammation and bacterial load³⁴. Understanding the underlying mechanism of each therapy allows clinicians to customize care effectively.

Advanced treatments like bacteriophages and probiotics are reshaping clinical protocols. These innovations address microbial imbalances, offering targeted solutions for persistent skin concerns³⁵. By integrating these therapies, we can improve long-term outcomes for patients.

Practical Insights for Clinicians

Effective integration of innovations requires a deep understanding of their mechanisms. For instance, retinoids normalize sebum production and reduce hyperkeratinization, making them a cornerstone of modern care³⁴. Clinicians must stay updated on emerging therapies to provide the best possible treatment.

Case examples highlight the importance of personalized approaches. A patient with severe lesions saw remarkable improvement after switching to a tailored regimen³⁵. This underscores the value of bridging research and practice for better results.

By focusing on evidence-based strategies, we can ensure that innovations are seamlessly integrated into clinical workflows. This approach not only enhances patient care but also sets new standards in dermatology.

Conclusion

As we conclude, it’s clear that addressing skin concerns requires a multifaceted approach. This disease is influenced by genetics, hormones, and lifestyle, making personalized care essential⁴. Recent advancements in both topical and systemic treatments have significantly improved outcomes for patients¹⁹.

Understanding the activity of key factors like sebum production and inflammation is crucial for effective management³. Ongoing research continues to uncover innovative therapies, offering hope for those with persistent concerns. By integrating scientific findings into clinical practice, we can provide better care tailored to individual needs.

In summary, a deep understanding of this disease and its underlying mechanisms is vital. Combining this knowledge with advancements in treatment ensures improved patient outcomes. The future of skin care lies in personalized, evidence-based approaches.

Source Links

1. Recent advances in understanding and managing acne – https://pmc.ncbi.nlm.nih.gov/articles/PMC7391011/
2. The changing landscape of acne therapeutics – https://www.dermatologytimes.com/view/changing-landscape-acne-therapeutics
3. Targeting Inflammation in Acne: Current Treatments and Future Prospects – American Journal of Clinical Dermatology – https://link.springer.com/article/10.1007/s40257-023-00789-1
4. Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies – https://pmc.ncbi.nlm.nih.gov/articles/PMC11121268/
5. Acne-induced pathological scars: pathophysiology and current treatments – https://pmc.ncbi.nlm.nih.gov/articles/PMC10998535/
6. Acne Vulgaris: Practice Essentials, Background, Pathophysiology – https://emedicine.medscape.com/article/1069804-overview
7. Hormonal treatment of acne vulgaris: an update – https://pmc.ncbi.nlm.nih.gov/articles/PMC5015761/
8. Hormone therapy in acne – https://ijdvl.com/hormone-therapy-in-acne/
9. Endocrine Disrupting Chemicals, Hormone Receptors, and Acne Vulgaris: A Connecting Hypothesis – https://www.mdpi.com/2073-4409/10/6/1439
10. Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies – https://www.mdpi.com/1422-0067/25/10/5302
11. An update on the role of the sebaceous gland in the pathogenesis of acne – https://pmc.ncbi.nlm.nih.gov/articles/PMC3051853/
12. Adult Female Acne: Recent Advances in Pathophysiology and Therapeutic Approaches – https://www.mdpi.com/2079-9284/11/3/74
13. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris – Microbiome – https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-018-0558-5
14. Potential Role of the Microbiome in Acne: A Comprehensive Review – https://pmc.ncbi.nlm.nih.gov/articles/PMC6678709/
15. Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances – https://pmc.ncbi.nlm.nih.gov/articles/PMC10709101/
16. Association of different cell types and inflammation in early acne vulgaris – https://pmc.ncbi.nlm.nih.gov/articles/PMC10864487/
17. Frontiers | Macrophages in acne vulgaris: mediating phagocytosis, inflammation, scar formation, and therapeutic implications – https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1355455/full
18. Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis – Dermatology and Therapy – https://link.springer.com/article/10.1007/s13555-021-00552-6
19. Frontiers | Acne treatment: research progress and new perspectives – https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1425675/full
20. Treatment Modalities for Acne – PMC – https://pmc.ncbi.nlm.nih.gov/articles/PMC6273829/
21. Acne Vulgaris: Diagnosis and Treatment – https://www.aafp.org/pubs/afp/issues/2019/1015/p475.html
22. Update on etiopathogenesis and treatment of Acne – https://ijdvl.com/update-on-etiopathogenesis-and-treatment-of-acne/
23. Topical Therapy for Acne – https://www.aafp.org/pubs/afp/issues/2000/0115/p357.html
24. PDF – https://cdn.mdedge.com/files/s3fs-public/Document/September-2017/023080356.pdf
25. What’s New After NICE Acne Guidelines – Dermatology and Therapy – https://link.springer.com/article/10.1007/s13555-024-01275-0
26. New acne treatments show promise – https://www.dermatologytimes.com/view/new-acne-treatments-show-promise
27. Acne Journal Club: What’s New in Disease Pathophysiology – https://www.medscape.org/viewarticle/934863_sidebar1
28. New developments in acne treatment: role of combination adapalene&ndas | TCRM – https://www.dovepress.com/new-developments-in-acne-treatment-role-of-combination-adapalenendashb-peer-reviewed-fulltext-article-TCRM
29. Addressing the Unmet Need in Acne Management: A Novel Dermocosmetics Guideline Tailored to Asian Patient Subgroups – https://www.mdpi.com/2079-9284/11/6/220
30. Next-Generation Therapies and Approaches Will Advance Acne Treatment – https://www.dermatologytimes.com/view/next-generation-therapies-and-approaches-will-advance-acne-treatment
31. ACNE VULGARIS TREATMENT : THE CURRENT SCENARIO – https://pmc.ncbi.nlm.nih.gov/articles/PMC3088940/
32. The Role of Inflammation in the Pathology of Acne – https://pmc.ncbi.nlm.nih.gov/articles/PMC3780801/
33. New insights into the role of Cutibacterium acnes-derived extracellular vesicles in inflammatory skin disorders – Scientific Reports – https://www.nature.com/articles/s41598-023-43354-w
34. Recent Trends in the Management of Acne Vulgaris: A Review Focusing on Clinical Studies in the Last Decade – https://pmc.ncbi.nlm.nih.gov/articles/PMC11031619/
35. Skin Microbiome and Acne: Microbial Imbalances and Impact – Interview with Three Key Opinion Leaders – https://www.emjreviews.com/dermatology/article/skin-microbiome-and-acne-microbial-imbalances-and-impact-interview-with-three-key-opinion-leaders-j030124/